181 related articles for article (PubMed ID: 25850729)
21.
Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
[TBL] [Abstract][Full Text] [Related]
22. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
Krueger E; Brown AC
Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.
Brown AC; Boesze-Battaglia K; Du Y; Stefano FP; Kieba IR; Epand RF; Kakalis L; Yeagle PL; Epand RM; Lally ET
Cell Microbiol; 2012 Jun; 14(6):869-81. PubMed ID: 22309134
[TBL] [Abstract][Full Text] [Related]
25. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
[TBL] [Abstract][Full Text] [Related]
26.
Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
[TBL] [Abstract][Full Text] [Related]
27. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells.
Dietmann A; Millonig A; Combes V; Couraud PO; Kachlany SC; Grau GE
Microb Pathog; 2013; 61-62():43-50. PubMed ID: 23665198
[TBL] [Abstract][Full Text] [Related]
28. Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model.
Stenderup K; Rosada C; Dam TN; Salerno E; Belinka BA; Kachlany SC
J Invest Dermatol; 2011 Oct; 131(10):2033-9. PubMed ID: 21654835
[TBL] [Abstract][Full Text] [Related]
29. Catechin-mediated restructuring of a bacterial toxin inhibits activity.
Chang EH; Huang J; Lin Z; Brown AC
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156
[TBL] [Abstract][Full Text] [Related]
30. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
[TBL] [Abstract][Full Text] [Related]
31. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
33. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
[TBL] [Abstract][Full Text] [Related]
34. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
Sampathkumar V; Velusamy SK; Godboley D; Fine DH
Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
[TBL] [Abstract][Full Text] [Related]
35. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.
Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET
Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
37. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
38. Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity.
Fong KP; Pacheco CM; Otis LL; Baranwal S; Kieba IR; Harrison G; Hersh EV; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2006 Nov; 8(11):1753-67. PubMed ID: 16827908
[TBL] [Abstract][Full Text] [Related]
39. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
Velusamy SK; Sampathkumar V; Godboley D; Fine DH
PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
[TBL] [Abstract][Full Text] [Related]
40. Solving the riddle: Unraveling the mechanisms of blocking the binding of leukotoxin by therapeutic antagonists in periodontal diseases.
Abdullahi M; Olotu FA; Soliman ME
J Cell Biochem; 2018 Nov; 119(11):9364-9379. PubMed ID: 30129224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
